✦ LIBER ✦

Introduction: Sentinel lymphadenectomy for patients with clinical stage I melanoma

✍ Scribed by Morton, Donald L.

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 24 KB
Volume: 66
Category: Article
ISSN: 0022-4790
DOI: 10.1002/(sici)1096-9098(199712)66:4<267::aid-jso9>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The sentinel lymph node status is an imp

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma

✍ Markwin G. Statius Muller; Paul A. M. van Leeuwen; Elly S. M de Lange-de Klerk; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

Follow-up recommendations for patients w

Follow-up recommendations for patients with American Joint Committee on Cancer Stages I–III malignant melanoma

✍ Wen-Jen Poo-Hwu; Stephan Ariyan; Lynne Lamb; Rose Papac; Daniel Zelterman; Grace 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## BACKGROUND. Guidelines for follow-up of melanoma patients are not established. In 1987, a follow-up protocol was instituted at the Yale Melanoma Unit to improve upon the detection of disease recurrence in patients with American Joint Committee on Cancer Stage I-III cutaneous melanoma. The foll

Multimodality therapy for patients with

Multimodality therapy for patients with clinical Stage I and II malignant mixed Müllerian tumors of the uterus

✍ Tom P. Manolitsas; Gerard V. Wain; Katherine E. Williams; Michael Freidlander; N 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 2 views

## BACKGROUND. The role of adjuvant therapy in the management of patients with malignant mixed Mu ¨llerian tumors (MMMT) of the uterus has not been defined. The outcome of planned multimodality therapy for patients with apparent early stage disease was assessed. ## METHODS. A pilot study was per

Prognostic risk factors that identify pa

Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis

✍ Axel Heidenreich; Isabell A. Sesterhenn; F. Kash Mostofi; Judd W. Moul 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Background: The purpose of this study was to develop a reliable model to identify clinical stage i nonseminomatous germ cell tumors (nsgcts) associated with low risk or high risk for occult retroperitoneal metastasis, so that the model could be used to customize the therapeutic approach for pati

A controversial issue: could a watch-and

A controversial issue: could a watch-and-wait policy for patients with non-Hodgkin's lymphoma clinical stage I or IE with no lymphoma left following diagnostic surgery be justified? Results of a single centre study

✍ Svetislav Jelić; Olivera Frim; Gordana Gligorijević; Dušica Gavrilović; Nebojša 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views

Background: A subset of patients with non-Hodgkin's lymphoma (NHL) with clinical stage I or IE at presentation is left without other NHL localizations following surgery performed for diagnostic histology, and thus without any target lesion to judge the immediate effectiveness of immediately applied